Biotek-snakken — Juni 2023
-
XBrane præsentation fra igår https://xbrane.com/wp-content/uploads/2023/05/Xbrane-INTERIM-REPORT-Q1-2023.pdf
-
Redeye Growth Day - 50 spændende virksomhedspræsentationer
"50 spændende virksomhedspræsentationer over tre parallelle streams. Vi kan garantere en begivenhed fuld af gennemtænkte spørgsmål, paneldiskussioner og overbevisende investeringscases."
(June 1 2023 08:58-17:00)
Storslået arrangementet af Redeye. Virkelig guf hvis du er til svensk biotek
Hansa Biopharma præsentation fra ca. minut 35:00 ...
-
Novo Nordisk In Talks To Acquire Controlling Stake In BIOCORP https://www.proinvestor.com/investornyt/996300/novo-nordisk-in-talks-to-acquire-controlling-stake-in-biocorp
-
-
Højt profileret læge og iværksætter med i Stenocares aktieudvidelse
https://www.proinvestor.com/boards/112991 -
Curasight A/S reports positive preclinical results with uTREAT[
] in aggressive brain cancer (glioblastoma)
7.6.2023 08.28 • MarketWire •Data from the study showed that uTREAT[
], when administered to a preclinical model of human aggressive brain cancer, effectively inhibited tumor growth. Animals receiving uTREAT[] survived longer compared to animals not treated with uTREAT[]. These data demonstrates the potential for uTREAT[] to be used as a radioligand the -
the treatment of aggressive brain cancer and supports further development for this treatment.
"We are extremely encouraged by these results, which further affirm our commitment to advancing our theranostic platform, comprising uTRACE[] and uTREAT[], for evaluation in patients with aggressive brain cancer. The urgent need to enhance therapeutic outcomes in this challenging disease drives our strategic pursuit," commented Ulrich Krasilnikoff, CEO of Curasight. -
An FDA advisory panel has voted 6-0 in
favour of recommending that Eisai and Biogen's Alzheimer's drug Leqembi be granted full approval. https://firstwordpharma.com/story/5750049 -
Stenocares emission overtegnet med 127% https://www.proinvestor.com/boards/113159
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind